(PharmaNewsWire.Com, June 18, 2021 ) The Infant Formula Ingredients Market is estimated USD 16.7 billion in 2019 and is projected to reach USD 25.5 billion by 2025, driven by its increasing demand from the developing Asia Pacific region. Urbanization has enabled mothers in this region to join workforce post giving birth, creating demand for infant formula and thus driving the demand for infant formula ingredients.
Additionally, some mothers unable to lactate; in such cases, infant formula is the most suited alternative available in the market. Several key food companies offer infant formula. Of these, Nestlé S.A. (Switzerland) stands among the most renowned. Apart from this, infant formula ingredients companies are involved in R&D, to come up with suitable ingredients as per the requirements of consumers.
The prebiotics segment is projected to be the fastest-growing in the infant formula ingredients market during the forecast period.
Usage of prebiotic ingredients in infant nutrition aids infant to overcome infections by providing health benefits. These include resisting gastrointestinal problems, building immunity, supporting increased mineral absorption, and lowering the tendency to become obese. Prebiotic ingredients used in infant formula include fructooligosaccharides, galactooligosaccharides, lactulose, polydextrose, and inulin. Boost in sales for infant formulas in the years to come will directly increase demand for infant formula ingredients.
The protein hydrolysate segment is projected to record the fastest growth during the forecast period.
Babies who are intolerant to both cow’s milk and soy-based formulas are given protein hydrolysate infant formula ingredients. These ingredients are obtained either through plant-based or animal-based sources. Some of the protein hydrolyzed based infant formula products include Enfamil Gentlease and Similac Sensitive. Several infant formula ingredients manufacturers are involved in R & D, to come up with ingredients as per the consumers demand, increasing sales of infant formula ingredients in the coming years derived from protein hydrolysate and other sources in the coming years.
The liquid & semi-liquid segment is projected to record the fastest growth during the forecast period.
Oils & fats are the most widely used liquid and semi-liquid ingredients for manufacturing infant formula. The liquid & semi-liquid segment is expected to exhibit high growth prospects in Asia Pacific. In Japan, liquid infant formulas are preferred owing to their convenience in emergencies such as natural disasters that frequently occur in the country.
Asia Pacific is projected to be the fastest-growing during the forecast period.
Asia Pacific infant formula ingredients market is projected to be the fastest-growing during the forecast period. Countries such as China, Japan, and South Korea are expected to be key revenue generators during the next few years. The region has seen a rapid transformation in terms of urbanization. This has enabled women to join workforce post-delivery, making infant formula the only nearest substitute to breast milk for infants. Apart from this, China remains a key market for infant formula ingredient manufacturers as the country has one of the highest numbers of births at the global level. The country relies on imported infant formulas from European countries.
Leading companies are AAK AB (Sweden), Fonterra Co-operative Group Limited (New Zealand), Carbery Food Ingredients Limited (Ireland), Royal Friesland Campina N.V. (Netherlands), Sachsenmilch Leppersdorf GmbH (Germany), BASF SE (Germany), Koninklijke DSM N.V. (Netherlands), Arla Foods amba (Denmark), Chr. Hansen Holdings A/S (Denmark), Kerry Group plc (Ireland), Lactalis Ingredients (France), Glanbia plc (Ireland), and Vitablend Nederland B.V. (Netherlands).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA : 1-888-600-6441
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
